368 related articles for article (PubMed ID: 19258354)
1. Memory performance is related to amyloid and tau pathology in the hippocampus.
Reitz C; Honig L; Vonsattel JP; Tang MX; Mayeux R
J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):715-21. PubMed ID: 19258354
[TBL] [Abstract][Full Text] [Related]
2. Activation of caspase-6 in aging and mild cognitive impairment.
Albrecht S; Bourdeau M; Bennett D; Mufson EJ; Bhattacharjee M; LeBlanc AC
Am J Pathol; 2007 Apr; 170(4):1200-9. PubMed ID: 17392160
[TBL] [Abstract][Full Text] [Related]
3. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.
Maass A; Lockhart SN; Harrison TM; Bell RK; Mellinger T; Swinnerton K; Baker SL; Rabinovici GD; Jagust WJ
J Neurosci; 2018 Jan; 38(3):530-543. PubMed ID: 29192126
[TBL] [Abstract][Full Text] [Related]
4. Visual association pathology in preclinical Alzheimer disease.
McKee AC; Au R; Cabral HJ; Kowall NW; Seshadri S; Kubilus CA; Drake J; Wolf PA
J Neuropathol Exp Neurol; 2006 Jun; 65(6):621-30. PubMed ID: 16783172
[TBL] [Abstract][Full Text] [Related]
5. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
[TBL] [Abstract][Full Text] [Related]
6. Amyloid-beta, tau, and dementia.
Takashima A
J Alzheimers Dis; 2009; 17(4):729-36. PubMed ID: 19542626
[TBL] [Abstract][Full Text] [Related]
7. Brainstem tau pathology in Alzheimer's disease is characterized by increase of three repeat tau and independent of amyloid β.
Uematsu M; Nakamura A; Ebashi M; Hirokawa K; Takahashi R; Uchihara T
Acta Neuropathol Commun; 2018 Jan; 6(1):1. PubMed ID: 29298724
[TBL] [Abstract][Full Text] [Related]
8. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation.
Yilmazer-Hanke DM; Hanke J
Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378
[TBL] [Abstract][Full Text] [Related]
9. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC
Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
[TBL] [Abstract][Full Text] [Related]
10. The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old.
García-Sierra F; Hauw JJ; Duyckaerts C; Wischik CM; Luna-Muñoz J; Mena R
Acta Neuropathol; 2000 Jul; 100(1):29-35. PubMed ID: 10912917
[TBL] [Abstract][Full Text] [Related]
11. Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD.
Sabbagh MN; Cooper K; DeLange J; Stoehr JD; Thind K; Lahti T; Reisberg B; Sue L; Vedders L; Fleming SR; Beach TG
Curr Alzheimer Res; 2010 Jun; 7(4):280-6. PubMed ID: 19715548
[TBL] [Abstract][Full Text] [Related]
12. Paucity of Entorhinal Cortex Pathology of the Alzheimer's Type in SuperAgers with Superior Memory Performance.
Gefen T; Kawles A; Makowski-Woidan B; Engelmeyer J; Ayala I; Abbassian P; Zhang H; Weintraub S; Flanagan ME; Mao Q; Bigio EH; Rogalski E; Mesulam MM; Geula C
Cereb Cortex; 2021 Jun; 31(7):3177-3183. PubMed ID: 33592091
[TBL] [Abstract][Full Text] [Related]
13. Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study.
Lace G; Savva GM; Forster G; de Silva R; Brayne C; Matthews FE; Barclay JJ; Dakin L; Ince PG; Wharton SB;
Brain; 2009 May; 132(Pt 5):1324-34. PubMed ID: 19321462
[TBL] [Abstract][Full Text] [Related]
14. A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal controls and non-Alzheimer neuropsychiatric diseases.
Muramori F; Kobayashi K; Nakamura I
Psychiatry Clin Neurosci; 1998 Dec; 52(6):593-9. PubMed ID: 9895207
[TBL] [Abstract][Full Text] [Related]
15. Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease.
Richter N; Bischof GN; Dronse J; Nellessen N; Neumaier B; Langen KJ; Drzezga A; Fink GR; van Eimeren T; Kukolja J; Onur OA
J Alzheimers Dis; 2020; 78(4):1601-1614. PubMed ID: 33164934
[TBL] [Abstract][Full Text] [Related]
16. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain.
Rohn TT; Rissman RA; Davis MC; Kim YE; Cotman CW; Head E
Neurobiol Dis; 2002 Nov; 11(2):341-54. PubMed ID: 12505426
[TBL] [Abstract][Full Text] [Related]
17. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment.
Guillozet AL; Weintraub S; Mash DC; Mesulam MM
Arch Neurol; 2003 May; 60(5):729-36. PubMed ID: 12756137
[TBL] [Abstract][Full Text] [Related]
18. Regional differences in Alzheimer's disease pathology confound behavioural rescue after amyloid-β attenuation.
Morrone CD; Bazzigaluppi P; Beckett TL; Hill ME; Koletar MM; Stefanovic B; McLaurin J
Brain; 2020 Jan; 143(1):359-373. PubMed ID: 31782760
[TBL] [Abstract][Full Text] [Related]
19. Tau deposition is associated with functional isolation of the hippocampus in aging.
Harrison TM; Maass A; Adams JN; Du R; Baker SL; Jagust WJ
Nat Commun; 2019 Oct; 10(1):4900. PubMed ID: 31653847
[TBL] [Abstract][Full Text] [Related]
20. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.
Guzman VA; Carmichael OT; Schwarz C; Tosto G; Zimmerman ME; Brickman AM;
Alzheimers Dement; 2013 Oct; 9(5 Suppl):S124-31. PubMed ID: 23375566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]